Maiwald Magazine

News and Releases

Maiwald Blog

11 Apr 2025 - Maiwald Blog

EPO Board of Appeal 3.3.04 is setting the right standard for acknowledging novelty of non-medical use claims (T 1913/21)

G 2/88 provides legal assessment for novelty of a non-medical use claim. G 2/88 allows acknowledging novelty of a non-medical use claim of an old compound for a particular pur...

Continue reading

8 Apr 2025 - Maiwald Blog

EPO revokes Roche’s Patent on combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer that was supported by results of Phase III AURELIA clinical trial

European Patent EP 2 825 558 concerns a combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer. The claim was supported by Phase III AURELIA c...

Continue reading

17 Jan 2025 - Maiwald Blog

UPDATE: New proceedings before the Enlarged Board of Appeal: “G2/24 – Skin cleanser”

On the issue of the potential continuation of EPO appeal proceedings by an intervener the questions for referral on which we already reported

Continue reading

All articles

Press Coverage

15 Apr 2025 - Press Coverage

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Cyprumed GmbH and Merck & Co., Inc. have entered a Non-Exclusive License and Option Agreement to develop oral formulations of peptides using Cyprumed’s drug delivery technology. MSD gains global non-exclusive rights...

Continue reading

2 Apr 2025 - Press Coverage

Managing IP names Maiwald one of the leading IP law firms in Germany

The market analysis by Managing IP and the IP STARS ranking 2024 confirm this: The German market for intellectual property remains dynamic and highly competitive. Especially in the field of patent law, numerous law firms were able to maintain and expand their leading positio...

Continue reading

11 Mar 2025 - Press Coverage

Roche gets Illumina unit’s DNA testing patent revoked

Roche has successfully persuaded a European appeals panel to revoke a patent held by Illumina’s subsidiary, Verinata Health, for detecting fetal DNA in maternal blood. The European Patent Office (EPO) ruled that the patent lacked an inventive step, as a prior application f...

Continue reading

Maiwald in the press

Staff News

4 Feb 2025 - Staff News

Maiwald congratulates Dr. Anna Closs on passing the exam

We congratulate Dr. Anna Closs on passing the German patent attorney examination!

Continue reading

8 Jan 2025 - Staff News

Maiwald appoints Dr. Lukas Delvos and Dr. Jian Sun as Counsel

Effective January 1, 2025, Maiwald, one of Germany's leading intellectual property law firms, appointed two new Counsel, Dr. Lukas Delvos and Dr. Jian Sun. Lukas Delvos until ...

Continue reading

29 Nov 2024 - Staff News

Maiwald congratulates on passing the exam

We would like to congratulate

Continue reading

All Staff News

Publications

30 Apr 2025 - Publication

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

This article covers the most recent developments regarding the European Research Exemption, which permits the use of patented inventions for research purposes, as well as the ...

Continue reading

30 Apr 2025 - Publication

The ‘long-arm’ of the Unified Patent Court – New developments in European cross-border patent litigation, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

The jurisdictional reach of the Unified Patent Court (UPC) was a widely and controversially discussed topic from the outset. Some practitioners took the view that the UPC also...

Continue reading

22 Apr 2025 - Publication

MAIinsight Issue 2 out now!

Continue reading

All publications

Awards

7 May 2025 - Award

Lexology honors Dr. Marco Stief as Thought Leader

We are delighted that our colleague Dr. Marco Stie...

Continue reading

29 Apr 2025 - Award

Maiwald voted one of the best commercial law firms of 2025 by brandeins and Statista

Using a two-stage survey and evaluation process that takes into account recommendations from lawyers, business and corporate clients, Statista, together with the business maga...

Continue reading

11 Apr 2025 - Award

Managing IP EMEA Awards 2025

Maiwald secures the EPO Proceedings Firm of the Year award of the highly competitive category

Continue reading

All awards

Events

Sun.

28

28 Sep 2025 |Upcoming|External Events

Maiwald at TMAP 2025 in Berlin, September 28-30, 2025

We are pleased to participate in the INTA Trademark Administrators & Practitioners (TMAP) Meeting 2025 in Berlin. This prestigious event brings together trademark administrators, patent paralegals, young professionals and attorneys working in the field of trademark law.The diverse conference program will cover current developments in trademark law and practical top...

Continue reading

Tue.

20

20 May 2025 |Past Event|LectureVortag Live

Joint symposium with Oblon in Tokyo on May 20, 2025

The Oblon and Maiwald firms are pleased to invite you to a complimentary joint international symposium on: U.S. and European Patent Practice: Important Aspects for Practitioners At the 2025 joint symposium, we will together examine selected current aspects of protecting innovation...

Continue reading

Sat.

17

17 May 2025 |Past Event|External Events

Maiwald at INTA’s 2025 Annual Meeting in San Diego

The International Trademark Association's (INTA) Annual Meeting took place in San Diego from May 17 to 21 this year. Maiwald was among the many companies and law firms in attendance, represented by Susanna Heurung,

Continue reading

Thu.

15

15 May 2025 |Past Event|SeminarSeminar

Maiwald Seminar on May 15

Patent law news: EPO case law, software and UPC (Lectures will be held in German) On May 15, we had the pleasure of hosting another Maiwald seminar in our office. Thank you to the speakers and everyone involved for making this an interesting afternoon and ensuring the event ran smoothly.

Continue reading

All events